Dr. Christopher J. Hupfeld, MD

Dr. Hupfeld practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Hupfeld's NPI, 1568429165, was assigned on April 27, 2006. Dr. Hupfeld graduated from Carver College of Medicine in 1996. Dr. Hupfeld's California license number on file is A064102.

Dr. Hupfeld's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Hupfeld's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Hupfeld is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hupfeld practices. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Hupfeld's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Hupfeld is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Hupfeld has a license on file in California.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, hypercalcemia, obesity, osteoporosis, overactive thyroid and parathyroid gland disorder among the conditions Dr. Hupfeld treats.

CMS data shows 496 Medicare services from Dr. Hupfeld across 5 procedure codes in 2024, for 373 Medicare patients. Medicare paid $49,723 for them. Every service was in an office.

CMS counts 373 Medicare patients who saw Dr. Hupfeld in 2024. The largest group is 65 to 74, with 175 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hupfeld's median patient age at 61, with 72% women.

In 2024, Dr. Hupfeld wrote 1,854 Medicare Part D claims for 314 patients. 49% of them were for generic drugs. CMS names the drug for 1,526 of them, across 37 drugs with 11 or more claims each, at $545,252 in total drug cost. In 2023, CMS named 1,307 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Hupfeld for performance year 2024, reported as part of a group. Dr. Hupfeld accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hupfeld as offering telehealth.

Dmand AI links 9 papers to Dr. Hupfeld, published from 2019 to 2020. The most frequent topics are Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2 and Hypoglycemic Agents. Dr. Hupfeld's most frequent co-authors are Sunder Mudaliar, MD and Preethika Subashini Ekanayake, MD.

CMS Open Payments shows 1 general payment to Dr. Hupfeld from 1 drug or device company in 2018. Consulting fees make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $200.

Dr. Hupfeld graduated from Carver College of Medicine in 1996.

Dr. Hupfeld is in network with 13 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.